Veterinary Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1066050
  • May 2021
  • Pharmaceuticals
  • 122 Pages
The Veterinary Vaccines Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Boehringer Ingelheim GmbH, Merck KGaA, Zoetis Inc., Eli Lilly and Company, Bayer AG, Ceva, Virbac, NEOGEN CORPORATION, Biovac, ImmuCell Corporation
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Veterinary Vaccines market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Veterinary Vaccines market is expected to attain Pre COVID-19 levels by mid-2022.

Veterinary Vaccines Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Veterinary Vaccines market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

Veterinary Vaccines Market Competitive and Premeditated Analysis
In the Veterinary Vaccines report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Veterinary Vaccines research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global Veterinary Vaccines Market:
The Veterinary Vaccines market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Boehringer Ingelheim GmbH, Merck KGaA, Zoetis Inc., Eli Lilly and Company, Bayer AG, Ceva, Virbac, NEOGEN CORPORATION, Biovac, ImmuCell Corporation

The Veterinary Vaccines market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Veterinary Vaccines Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the Veterinary Vaccines market:
by Vaccine Type
Livestock Vaccines
Companion Animal Vaccines
Technology
Live Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines

Regional Analysis of the Veterinary Vaccines market:
The Veterinary Vaccines market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the Veterinary Vaccines report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Veterinary Vaccines market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Veterinary Vaccines market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Veterinary Vaccines market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Veterinary Vaccines market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Veterinary Vaccines market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Veterinary Vaccines market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Veterinary Vaccines market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Veterinary Vaccines market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Boehringer Ingelheim GmbH
  • Merck KGaA
  • Zoetis Inc.
  • Eli Lilly and Company
  • Bayer AG
  • Ceva
  • Virbac
  • NEOGEN CORPORATION
  • Biovac
  • ImmuCell Corporation
  • Livestock Vaccines
  • Companion Animal Vaccines
  • Live Attenuated Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Conjugate Vaccines

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Veterinary Vaccines Market Snapshot
          2.1.1. Global Veterinary Vaccines Market By Vaccine Type,2019
               2.1.1.1.Livestock Vaccines
               2.1.1.2.Companion Animal Vaccines
          2.1.2. Global Veterinary Vaccines Market By Technology,2019
               2.1.2.1.Live Attenuated Vaccines
               2.1.2.2.Inactivated Vaccines
               2.1.2.3.Toxoid Vaccines
               2.1.2.4.Recombinant Vaccines
               2.1.2.5.Conjugate Vaccines
          2.1.3. Global Veterinary Vaccines Market By End-use,2019
          2.1.4. Global Veterinary Vaccines Market By Geography,2019

3. Global Veterinary Vaccines Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Veterinary Vaccines Market Size (US$), By Vaccine Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Vaccine Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Vaccine Type, 2020
     4.2. Global Veterinary Vaccines Market Size (US$), By Vaccine Type, 2018 – 2028

5. Global Veterinary Vaccines Market Size (US$), By Technology, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Technology, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Technology, 2020
     5.2. Global Veterinary Vaccines Market Size (US$), By Technology, 2018 – 2028

6. Global Veterinary Vaccines Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Veterinary Vaccines Market Size (US$), By End-use, 2018 – 2028

7. Global Veterinary Vaccines Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Veterinary Vaccines Market Analysis, 2018 – 2028 
          7.2.1. North America Veterinary Vaccines Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Veterinary Vaccines Market Size (US$), By Vaccine Type, 2018 – 2028
          7.2.3. North America Veterinary Vaccines Market Size (US$), By Technology, 2018 – 2028
          7.2.4. North America Veterinary Vaccines Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Veterinary Vaccines Market Analysis, 2018 – 2028 
          7.3.1.  Europe Veterinary Vaccines Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Veterinary Vaccines Market Size (US$), By Vaccine Type, 2018 – 2028
          7.3.3. Europe Veterinary Vaccines Market Size (US$), By Technology, 2018 – 2028
          7.3.4. Europe Veterinary Vaccines Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Veterinary Vaccines Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Veterinary Vaccines Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Veterinary Vaccines Market Size (US$), By Vaccine Type, 2018 – 2028
          7.4.3. Asia Pacific Veterinary Vaccines Market Size (US$), By Technology, 2018 – 2028
          7.4.4. Asia Pacific Veterinary Vaccines Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Veterinary Vaccines Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Veterinary Vaccines Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Veterinary Vaccines Market Size (US$), By Vaccine Type, 2018 – 2028
          7.5.3. Latin America Veterinary Vaccines Market Size (US$), By Technology, 2018 – 2028
          7.5.4. Latin America Veterinary Vaccines Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Veterinary Vaccines Market Analysis, 2018 – 2028 
          7.6.1.  MEA Veterinary Vaccines Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Veterinary Vaccines Market Size (US$), By Vaccine Type, 2018 – 2028
          7.6.3. MEA Veterinary Vaccines Market Size (US$), By Technology, 2018 – 2028
          7.6.4. MEA Veterinary Vaccines Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Veterinary Vaccines Providers
        8.4.1 Boehringer Ingelheim GmbH
                8.4.1.1 Business Description
                8.4.1.2 Boehringer Ingelheim GmbH Geographic Operations
                8.4.1.3 Boehringer Ingelheim GmbH Financial Information
                8.4.1.4 Boehringer Ingelheim GmbH Product Positions/Portfolio
                8.4.1.5 Boehringer Ingelheim GmbH Key Developments
        8.4.2 Merck KGaA
                8.4.2.1 Business Description
                8.4.2.2 Merck KGaA Geographic Operations
                8.4.2.3 Merck KGaA Financial Information
                8.4.2.4 Merck KGaA Product Positions/Portfolio
                8.4.2.5 Merck KGaA Key Developments
        8.4.3 Zoetis Inc.
                8.4.3.1 Business Description
                8.4.3.2 Zoetis Inc. Geographic Operations
                8.4.3.3 Zoetis Inc. Financial Information
                8.4.3.4 Zoetis Inc. Product Positions/Portfolio
                8.4.3.5 Zoetis Inc. Key Developments
        8.4.4 Eli Lilly and Company
                8.4.4.1 Business Description
                8.4.4.2 Eli Lilly and Company Geographic Operations
                8.4.4.3 Eli Lilly and Company Financial Information
                8.4.4.4 Eli Lilly and Company Product Positions/Portfolio
                8.4.4.5 Eli Lilly and Company Key Developments
        8.4.5 Bayer AG
                8.4.5.1 Business Description
                8.4.5.2 Bayer AG Geographic Operations
                8.4.5.3 Bayer AG Financial Information
                8.4.5.4 Bayer AG Product Positions/Portfolio
                8.4.5.5 Bayer AG Key Developments
        8.4.6 Ceva
                8.4.6.1 Business Description
                8.4.6.2 Ceva Geographic Operations
                8.4.6.3 Ceva Financial Information
                8.4.6.4 Ceva Product Positions/Portfolio
                8.4.6.5 Ceva Key Developments
        8.4.7 Virbac
                8.4.7.1 Business Description
                8.4.7.2 Virbac Geographic Operations
                8.4.7.3 Virbac Financial Information
                8.4.7.4 Virbac Product Positions/Portfolio
                8.4.7.5 Virbac Key Developments
        8.4.8 NEOGEN CORPORATION
                8.4.8.1 Business Description
                8.4.8.2 NEOGEN CORPORATION Geographic Operations
                8.4.8.3 NEOGEN CORPORATION Financial Information
                8.4.8.4 NEOGEN CORPORATION Product Positions/Portfolio
                8.4.8.5 NEOGEN CORPORATION Key Developments
        8.4.9 Biovac
                8.4.9.1 Business Description
                8.4.9.2 Biovac Geographic Operations
                8.4.9.3 Biovac Financial Information
                8.4.9.4 Biovac Product Positions/Portfolio
                8.4.9.5 Biovac Key Developments
        8.4.10 ImmuCell Corporation
                8.4.10.1 Business Description
                8.4.10.2 ImmuCell Corporation Geographic Operations
                8.4.10.3 ImmuCell Corporation Financial Information
                8.4.10.4 ImmuCell Corporation Product Positions/Portfolio
                8.4.10.5 ImmuCell Corporation Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Veterinary Vaccines Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Veterinary Vaccines Market Revenue, By Vaccine Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Veterinary Vaccines Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Veterinary Vaccines Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Veterinary Vaccines Market Revenue, By Vaccine Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Veterinary Vaccines Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Veterinary Vaccines Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Veterinary Vaccines Market Revenue, By Vaccine Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Veterinary Vaccines Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Veterinary Vaccines Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Veterinary Vaccines Market Revenue, By Vaccine Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Veterinary Vaccines Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Veterinary Vaccines Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Veterinary Vaccines Market Revenue, By Vaccine Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Veterinary Vaccines Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Veterinary Vaccines Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Veterinary Vaccines: Market Segmentation 
FIG. 2 Global Veterinary Vaccines Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Veterinary Vaccines Market, By Vaccine Type, 2019 (US$ Mn) 
FIG. 5 Global Veterinary Vaccines Market, By Technology, 2019 (US$ Mn) 
FIG. 6 Global Veterinary Vaccines Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Veterinary Vaccines Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Veterinary Vaccines Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Veterinary Vaccines Providers, 2019
FIG. 11 Global Veterinary Vaccines Market Revenue Contribution, By Vaccine Type, 2019 & 2028 (Value %) 
FIG. 12 Global Veterinary Vaccines Market Revenue Contribution, By Technology, 2019 & 2028 (Value %) 
FIG. 13 Global Veterinary Vaccines Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Veterinary Vaccines Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Veterinary Vaccines Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Veterinary Vaccines Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Veterinary Vaccines Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Veterinary Vaccines Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Veterinary Vaccines market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Veterinary Vaccines Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Veterinary Vaccines Market Value, By Segment1, 2018 – 2028
TABLE  North America Veterinary Vaccines Market Value, By Segment2, 2018 – 2028
TABLE  North America Veterinary Vaccines Market Value, By Country, 2018 – 2028
TABLE  Europe Veterinary Vaccines Market Value, By Segment1, 2018 – 2028
TABLE  Europe Veterinary Vaccines Market Value, By Segment2, 2018 – 2028
TABLE  Europe Veterinary Vaccines Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Veterinary Vaccines Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Veterinary Vaccines Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Veterinary Vaccines Market Value, By Country, 2018 – 2028
TABLE  Latin America Veterinary Vaccines Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Veterinary Vaccines Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Veterinary Vaccines Market Value, By Country, 2018 – 2028
TABLE  MEA Veterinary Vaccines Market Value, By Segment1, 2018 – 2028
TABLE  MEA Veterinary Vaccines Market Value, By Segment2, 2018 – 2028
TABLE  MEA Veterinary Vaccines Market Value, By Country, 2018 – 2028
TABLE  Boehringer Ingelheim GmbH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck KGaA: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Zoetis Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Eli Lilly and Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bayer AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Ceva: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Virbac: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  NEOGEN CORPORATION: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Biovac: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  ImmuCell Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Veterinary Vaccines Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Veterinary Vaccines Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Veterinary Vaccines Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Veterinary Vaccines Market, By Geography, 2019 (US$ Mn)
FIG.  Global Veterinary Vaccines Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Veterinary Vaccines Providers, 2016
FIG.  Global Veterinary Vaccines Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Companion Animal Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Veterinary Vaccines Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Inactivated Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Toxoid Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Recombinant Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Conjugate Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Veterinary Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Veterinary Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Veterinary Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Veterinary Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Veterinary Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Veterinary Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Veterinary Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Veterinary Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Veterinary Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Veterinary Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Veterinary Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Veterinary Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Veterinary Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Veterinary Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Veterinary Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Veterinary Vaccines Market Value, 2018 – 2028, (US$ Mn)